News for 'Ranbaxy Laboratories Ltd'

Fortis' Shivinder Singh to step down; to join spiritual organisation

Fortis' Shivinder Singh to step down; to join spiritual organisation

Rediff.com23 Sep 2015

Fortis Healthcare Executive Vice-Chairman Shivinder Mohan Singh is stepping down from his position to join a philosophical and spiritual organisation.

Sensex, Nifty post biggest single-day fall in 2 months

Sensex, Nifty post biggest single-day fall in 2 months

Rediff.com9 Mar 2015

The 30-share Sensex ended down 604 points at 28,845 and the 50-share Nifty ended down 181 points at 8,757. The Bank Nifty ended down 602 points at 19,146.

Walmart's $16 bn Flipkart buy is the biggest deal this year

Walmart's $16 bn Flipkart buy is the biggest deal this year

Rediff.com9 May 2018

Sachin Bansal, who had co-founded Flipkart with Binny Bansal in 2007, would exit the company

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

How the private sector has stalled India's reforms

How the private sector has stalled India's reforms

Rediff.com9 Jul 2018

'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

Rediff.com13 Jan 2014

The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

« Prev  |